MARKET

PRFX

PRFX

PAINREFORM LTD.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.050
+0.130
+4.45%
After Hours: 3.040 -0.01 -0.33% 18:17 09/24 EDT
OPEN
2.970
PREV CLOSE
2.920
HIGH
3.090
LOW
2.931
VOLUME
72.68K
TURNOVER
--
52 WEEK HIGH
7.84
52 WEEK LOW
2.180
MARKET CAP
27.22M
P/E (TTM)
-6.5903
1D
5D
1M
3M
1Y
5Y
20 Stocks Moving in Tuesday's Pre-Market Session
Gainers Communications Systems, Inc. (NASDAQ: JCS) rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share.
Benzinga · 09/14 11:13
BRIEF-PainReform Ltd Files For Mixed Shelf Of Up To $100 Million
reuters.com · 09/03 20:40
WDAY, DVAX and BILL among pre market gainers.
Support.com (NASDAQ:SPRT) +59%. Navios Maritime Acquisition NNA +47% on merger agreement with Navios Maritime Partners NeuroMetrix (NASDAQ:NURO) +30%. PainReform  (NASDAQ:PRFX) +22%. Bill.com BILL +15% on Q4 earnings. TSR  (NASDAQ:TSRI) +15%. Taoping  (NAS...
Seekingalpha · 08/27 12:22
PainReform reports Q2 results
PainReform (NASDAQ:PRFX): incurred a net loss of $3.7 million for the six months ended June 30, 2021 compared to a net loss of $2.0 million for the six months ended
Seekingalpha · 08/16 12:46
PainReform Provides Business Update for the Second Quarter of 2021
PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the second quarter ended June 30, 2021.
GlobeNewswire · 08/16 12:00
63 Biggest Movers From Yesterday
Gainers
Benzinga · 08/02 09:12
74 Biggest Movers From Yesterday
Gainers
Benzinga · 07/27 09:14
Pinduoduo, DiDi Global, KE Holdings among premarket losers' pack
Iterum Therapeutics plc (ITRM) -43% after announcing FDA’s Complete Response Letter for sulopenem.ATI Physical Therapy, Inc. (ATIP) -25% on Q2 earnings releaseNew Oriental Education & Technology Group Inc. (EDU) -24% provides update on new regulations.Chin...
Seekingalpha · 07/26 12:35
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PRFX. Analyze the recent business situations of PAINREFORM LTD. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PRFX stock price target is 6.00 with a high estimate of 6.00 and a low estimate of 6.00.
EPS
Institutional Holdings
Institutions: 7
Institutional Holdings: 435.53K
% Owned: 4.88%
Shares Outstanding: 8.93M
TypeInstitutionsShares
Increased
3
25.33K
New
2
29.16K
Decreased
0
0
Sold Out
1
839.35K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About PRFX
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

Webull offers kinds of PainReform Ltd stock information, including NASDAQ:PRFX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRFX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRFX stock methods without spending real money on the virtual paper trading platform.